P. Andersen and S. Kaufmann, Novel vaccination strategies against tuberculosis. Cold Spring Harb Perspect Med, 2014.

G. Delogu, R. Manganelli, and M. Brennan, Critical research concepts in tuberculosis vaccine development, Clinical Microbiology and Infection, vol.20, issue.11, pp.59-65, 2014.
DOI : 10.1111/1469-0691.12460

A. Pym, P. Brodin, L. Majlessi, R. Brosch, C. Demangel et al., Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis, Nature Medicine, vol.9, issue.5, pp.533-542, 2003.
DOI : 10.1038/nm859

G. Mahairas, P. Sabo, M. Hickey, D. Singh, and C. Stover, Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis., Journal of Bacteriology, vol.178, issue.5, pp.1274-82, 1996.
DOI : 10.1128/jb.178.5.1274-1282.1996

M. Behr, M. Wilson, W. Gill, H. Salamon, G. Schoolnik et al., Comparative Genomics of BCG Vaccines by Whole-Genome DNA Microarray, Science, vol.284, issue.5419, pp.1520-1523, 1999.
DOI : 10.1126/science.284.5419.1520

F. Bange, F. Collins, W. Jacobs, and J. , Survival of mice infected with Mycobacterium smegmatis containing large DNA fragments from Mycobacterium tuberculosis, Tubercle and Lung Disease, vol.79, issue.3, pp.171-80, 1999.
DOI : 10.1054/tuld.1998.0201

W. Bitter, E. Houben, D. Bottai, P. Brodin, E. Brown et al., Systematic Genetic Nomenclature for Type VII Secretion Systems, PLoS Pathogens, vol.23, issue.10, p.1000507, 2009.
DOI : 10.1371/journal.ppat.1000507.s002

R. Simeone, F. Sayes, O. Song, M. Groschel, P. Brodin et al., Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo, PLOS Pathogens, vol.25, issue.2, p.1004650, 2015.
DOI : 10.1371/journal.ppat.1004650.s007

A. Pym, P. Brodin, R. Brosch, M. Huerre, and S. Cole, Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti, Molecular Microbiology, vol.232, issue.Suppl., pp.709-726, 2002.
DOI : 10.1046/j.1365-2958.2002.03237.x

P. Brodin, L. Majlessi, R. Brosch, D. Smith, G. Bancroft et al., Vaccine That Induces T Cell Immunity against Region of Difference 1 Antigens, The Journal of Infectious Diseases, vol.190, issue.1, pp.115-137, 2004.
DOI : 10.1086/421468

P. Brodin, M. De-jonge, L. Majlessi, C. Leclerc, M. Nilges et al., Functional Analysis of Early Secreted Antigenic Target-6, the Dominant T-cell Antigen of Mycobacterium tuberculosis, Reveals Key Residues Involved in Secretion, Complex Formation, Virulence, and Immunogenicity, Journal of Biological Chemistry, vol.280, issue.40, pp.33953-33962, 2005.
DOI : 10.1074/jbc.M503515200

S. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher et al., Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence, Nature, vol.25, issue.6685, pp.537-581, 1998.
DOI : 10.1038/31159

P. Sander, S. Clark, A. Petrera, C. Vilaplana, M. Meuli et al., Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis, Vaccine, vol.33, issue.11, pp.1353-1362, 2015.
DOI : 10.1016/j.vaccine.2015.01.058

C. Demangel, P. Brodin, P. Cockle, R. Brosch, L. Majlessi et al., Cell Envelope Protein PPE68 Contributes to Mycobacterium tuberculosis RD1 Immunogenicity Independently of a 10-Kilodalton Culture Filtrate Protein and ESAT-6, Infection and Immunity, vol.72, issue.4, pp.2170-2176, 2004.
DOI : 10.1128/IAI.72.4.2170-2176.2004

D. Bottai, L. Majlessi, R. Simeone, W. Frigui, C. Laurent et al., ESAT-6 Secretion-Independent Impact of ESX-1 Genes espF and espG1 on Virulence of Mycobacterium tuberculosis, Journal of Infectious Diseases, vol.203, issue.8, pp.1155-64, 2011.
DOI : 10.1093/infdis/jiq089

A. Williams, A. Davies, P. Marsh, M. Chambers, and R. Hewinson, Comparison of the Protective Efficacy of Bacille Calmette-Guerin Vaccination against Aerosol Challenge with Mycobacterium tuberculosis and Mycobacterium bovis, Clinical Infectious Diseases, vol.30, issue.Supplement 3, pp.299-301, 2000.
DOI : 10.1086/313878

M. Chambers, A. Williams, D. Gavier-widen, A. Whelan, G. Hall et al., Identification of a Mycobacterium bovis BCG Auxotrophic Mutant That Protects Guinea Pigs against M. bovis and Hematogenous Spread of Mycobacterium tuberculosis without Sensitization to Tuberculin, Infection and Immunity, vol.68, issue.12, pp.7094-7103, 2000.
DOI : 10.1128/IAI.68.12.7094-7099.2000

A. Williams, B. James, J. Bacon, K. Hatch, G. Hatch et al., An assay to compare the infectivity of Mycobacterium tuberculosis isolates based on aerosol infection of guinea pigs and assessment of bacteriology, Tuberculosis, vol.85, issue.3, pp.177-84, 2005.
DOI : 10.1016/j.tube.2004.11.001

R. Brosch, S. Gordon, T. Garnier, K. Eiglmeier, W. Frigui et al., Genome plasticity of BCG and impact on vaccine efficacy, Proceedings of the National Academy of Sciences, vol.104, issue.13, pp.5596-601, 2007.
DOI : 10.1073/pnas.0700869104

A. Williams, G. Hatch, S. Clark, K. Gooch, K. Hatch et al., Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis, Tuberculosis, vol.85, issue.1-2, pp.29-38, 2005.
DOI : 10.1016/j.tube.2004.09.009

L. Grode, P. Seiler, S. Baumann, J. Hess, V. Brinkmann et al., Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin, Journal of Clinical Investigation, vol.115, issue.9, pp.2472-2481, 2005.
DOI : 10.1172/JCI24617

B. Lopez, D. Aguilar, H. Orozco, M. Burger, C. Espitia et al., A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes, Clinical and Experimental Immunology, vol.102, issue.1, pp.30-37, 2003.
DOI : 10.1001/jama.275.6.452

A. Arbues, J. Aguilo, J. Gonzalo-asensio, D. Marinova, S. Uranga et al., Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials, Vaccine, vol.31, issue.42, pp.4867-73, 2013.
DOI : 10.1016/j.vaccine.2013.07.051

I. Orme, Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines, Infect Immun, vol.56, pp.3310-3312, 1988.

F. Romain, J. Pescher, P. Marchal, and G. , Isolation of a proline-rich mycobacterial protein eliciting delayed-type hypersensitivity reactions only in guinea pigs immunized with living mycobacteria., Proceedings of the National Academy of Sciences, vol.90, issue.11, pp.5322-5328, 1993.
DOI : 10.1073/pnas.90.11.5322

R. Simeone, A. Bobard, J. Lippmann, W. Bitter, L. Majlessi et al., Phagosomal Rupture by Mycobacterium tuberculosis Results in Toxicity and Host Cell Death, PLoS Pathogens, vol.203, issue.2, p.1002507, 2012.
DOI : 10.1371/journal.ppat.1002507.s009

D. Houben, C. Demangel, J. Van-ingen, J. Perez, L. Baldeon et al., ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria, Cellular Microbiology, vol.6, issue.8, pp.1287-98, 2012.
DOI : 10.1111/j.1462-5822.2012.01799.x

W. Frigui, D. Bottai, L. Majlessi, M. Monot, E. Josselin et al., Control of M. tuberculosis ESAT-6 Secretion and Specific T Cell Recognition by PhoP, PLoS Pathogens, vol.74, issue.2, p.33, 2008.
DOI : 10.1371/journal.ppat.0040033.st002
URL : https://hal.archives-ouvertes.fr/pasteur-01370872

J. Lee, R. Krause, J. Schreiber, H. Mollenkopf, J. Kowall et al., Mutation in the Transcriptional Regulator PhoP Contributes to Avirulence of Mycobacterium tuberculosis H37Ra Strain, Cell Host & Microbe, vol.3, issue.2, pp.97-103, 2008.
DOI : 10.1016/j.chom.2008.01.002

E. Boritsch, P. Supply, N. Honore, T. Seeman, T. Stinear et al., A glimpse into the past and predictions for the future: the molecular evolution of the tuberculosis agent, Molecular Microbiology, vol.69, issue.5, pp.835-52, 2014.
DOI : 10.1111/mmi.12720

S. Gagneux and P. Small, Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development, The Lancet Infectious Diseases, vol.7, issue.5, pp.328-365, 2007.
DOI : 10.1016/S1473-3099(07)70108-1

I. Orme and R. Basaraba, The formation of the granuloma in tuberculosis infection, Seminars in Immunology, vol.26, issue.6, pp.601-610, 2014.
DOI : 10.1016/j.smim.2014.09.009

C. Martin, A. Williams, R. Hernandez-pando, P. Cardona, E. Gormley et al., The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs, Vaccine, vol.24, issue.17, pp.3408-3427, 2006.
DOI : 10.1016/j.vaccine.2006.03.017

K. Sweeney, D. Dao, M. Goldberg, T. Hsu, M. Venkataswamy et al., A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis, Nature Medicine, vol.13, issue.10, pp.1261-1269, 2011.
DOI : 10.1038/35105052

F. Sayes, L. Sun, D. Luca, M. Simeone, R. Degaiffier et al., Strong Immunogenicity and Cross-Reactivity of Mycobacterium tuberculosis ESX-5 Type VII Secretion -Encoded PE-PPE Proteins Predicts Vaccine Potential, Cell Host & Microbe, vol.11, issue.4, pp.352-63, 2012.
DOI : 10.1016/j.chom.2012.03.003
URL : https://hal.archives-ouvertes.fr/pasteur-01104794

M. Horwitz and G. Harth, A New Vaccine against Tuberculosis Affords Greater Survival after Challenge than the Current Vaccine in the Guinea Pig Model of Pulmonary Tuberculosis, Infection and Immunity, vol.71, issue.4, pp.1672-1681, 2003.
DOI : 10.1128/IAI.71.4.1672-1679.2003

M. Gengenbacher, A. Vogelzang, S. Schuerer, D. Lazar, P. Kaiser et al., Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guerin DeltaureC::hly Deltapdx1 in mice, MBio, vol.5, pp.1262-1276, 2014.

M. Pallen, The ESAT-6/WXG100 superfamily ??? and a new Gram-positive secretion system?, Trends in Microbiology, vol.10, issue.5, pp.209-221, 2002.
DOI : 10.1016/S0966-842X(02)02345-4